Skip to main content
Premium Trial:

Request an Annual Quote

GenapSys: Britton Russell, Mary Stewart, Surekha Karudapuram

GenapSys has added Britton Russell as CFO, Mary Stewart as chief operating officer, and Surekha Karudapuram as VP of product management and marketing.

Russell comes to GenapSys from Invitae and ArcherDx, where he was senior VP of finance (Invitae acquired ArcherDx in October 2020.) Russell also has experience at AstraZeneca, Genentech, and Royal Dutch Shell. Russell holds an MBA from Rice University.

Stewart also comes to GenapSys from Invitae, where she was VP for global diagnostic strategy. She brings over 20 years of experience as a hospital administrator. Stewart holds an MBA and master's degree in health services administration from Arizona State University.

Karudapuram brings a decade of experience in product management and marketing. Most recently, she was at GALT, where she led marketing and applications for microbiome analysis. She has also worked at Varian Medical Systems, Life Technologies, and Agilent. She holds a doctorate from the University of Maryland.

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.